Methylphenidate dosing: Twice daily versus three times daily

Pediatrics

Volumn 98, Issue 4 PART 1, 1996, Pages 748-756

  Stein, Mark A ^a,d   Blondis, Thomas A ^a   Schnitzler, Eugene R ^b   O'Brien, Tara ^a   Fishkin, Julie ^a   Blackwell, Brad ^c   Szumowski, Emily ^a   Roizen, Nancy J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Private Practice   (United States)

^c ADVOCATE LUTHERAN GENERAL HOSPITAL   (United States)

^d Section of Child and Adolescent Psychiatry   (United States)

Author keywords

Attention deficit hyperactivity disorder; Dosing; Methylphenidate; Side effects; Sleep

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ANOREXIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; IMPULSIVENESS; MALE; MINIMAL BRAIN DYSFUNCTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CAPSULES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD BEHAVIOR; COGNITION; FOLLOW-UP STUDIES; HUMANS; MALE; METHYLPHENIDATE; SLEEP; TIME FACTORS;

EID: 0029818942     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bradley C. The behavior of children receiving benzedrine. Am J Psychiatry. 1937;94:577-585
2. Barkley RA. A review of stimulant drug research with hyperactive children. J Child Psychol Psychiatry. 1977;18:137-165
3. Copeland L, Wolraich M, Lindgren S, Milich R, Woolson R. Pediatricians' reported practices in the assessment and treatment of attention deficit disorders. J Dev Behav Pediatr. 1987;8:191-197
4. DuPaul GJ, Barkley RA. Medication therapy. In: Barkley RA, ed. Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guilford Press; 1990
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994
6. Klein RG, Wender P. The role of methylphenidate in psychiatry [commentary]. Arch Gen Psychiatry. 1995;52:429-433
7. Swanson JM, McBurnett K, Christian DL, Wigal T. Stimulant medications and the treatment of children with ADHD. In: Ollendick TH, Prinz RJ, eds. Advances in Clinical Child Psychology. New York: Plenum Press; 1995;17:265-322
8. Shaywitz SE, Shaywitz BA. Attention deficit disorder: diagnosis and role of Ritalin in management. In: Greenhill LL, Osman BB, eds. Ritalin: Theory and Patient Management. New York: Mary Ann Liebert Inc; 1991
9. Klein RG, Bessler AW. Stimulant side effects in children. In: Kane JM, Lieberman JA, eds. Adverse Effects of Psychotropic Drugs. New York: Guilford Press; 1992
10. Ahmann PA, Waltonen SJ, Olson KA, Theye FW, Van Erem AJ, LaPlant R. Placebo-controlled evaluation of Ritalin side effects. Pediatrics. 1993; 91:1101-1106
11. Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systematic, placebo-controlled evaluation. Pediatrics. 1990; 86:184-192
12. Gadow KD, Sverd J, Sprafkin J, Nolan EE, Ezor SN. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry. 1995;52:444-455
13. Fitzpatrick PA, Klorman R, Brumaghim JT, Borgstedt AD. Effects of sustained-release and standard preparations of methylphenidate on attention deficit disorder. J Am Acad Child Adolesc Psychiatry. 1992;31: 226-234
14. Kent JD, Blader JC, Koplewicz HS, Abikoff H, Foley CA. Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Pediatrics. 1995;96:320-325
15. Pelham WE Jr, Greenslade KE, Vodde-Hamilton M, et al. The efficacy of long-acting stimulants on ADHD children: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline. Pediatrics. 1990;86:226-237
16. Sherman M, Hertzig ME. Prescribing practices of Ritalin: the Suffolk County, New York study. In: Greenhill LL, Osman BB, eds. Ritalin: Theory and Patient Management. New York: Mary Ann Liebert Inc; 1991
17. Roizen NJ, Blondis TA, Irwin M, Stein MA. Adaptive functioning in children with attention deficit hyperactivity disorder. Arch Pediatr Adolesc Medicine. 1994;148:1137-1142Stein MA,
18. Stein MA, Szumowski E, Blondis TA, Roizen NJ. Adaptive skills dysfunction in ADD and ADHD children. J Child Psychol Psychiatry. 1995; 36:663-670
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, rev. Washington, DC: American Psychiatric Association; 1987
20. National Institute of Mental Health (NIMH). NIMH Diagnostic Interview Schedule for Children (DISC-2.3, parent version). Washington, DC: NIMH; 1992
21. Edelbrock C, Costello AJ, Dulcan MK, Kalas R, Conover NC. Age differences in the reliability of the psychiatric interview of the child. Child Dev. 1985;56:265-275
22. Lahey BB, Loeber R, Stouthamer-Loeber M, et al. Comparison of DSM-III and DSM-III-R diagnoses for prepubertal children: changes in prevalence and validity. J Am Acad Child Adolesc Psychiatry. 1990; 29:620-626
23. Goyette CH, Conners CK, Ulrich RF. Normative data on revised Conners Parent and Teacher Rating Scales. J Abnorm Child Psychol. 1978;6: 221-236
24. Achenbach TM. Manual for the Child Behavior Checklist and Revised Child Behavior Profile. Burlington, VT. University of Vermont, Department of Psychiatry; 1991
25. Ullmann RK, Sleator EK, Sprague RL. A new rating scale for diagnosis and monitoring of ADD children. Psychopharmacol Bull. 1984;20:160-164
26. Frankel F, Weiner H. The child conflict index: factor analysis, reliability, and validity for clinic-referred and nonreferred children. J Clin Child Psychol. 1990;19:239-248
27. Ferber RA. Solve Your Child's Sleep Problem. New York. Simon and Schuster; 1985
28. Ambulatory Monitoring, Inc. User's Guide for the Motionlogger Actigraph Mini. Revision 1.5. Ardsley, NY: Ambulatory Monitoring, Inc; 1990
29. Sadeh A, Sharkey KM, Carskadon MA. Activity-based sleep-wake identification: an empirical test of methodological issues. Sleep. 1994;17: 201-207
30. Greenberg L, Waldman ID. Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry. 1993;34: 1019-1030
31. Greenberg L. T.O.V.A. Interpretation Manual. Minneapolis, MN: 1991
32. Kovacs M. The Children's Depression Inventory. Psychopharmacol Bull. 1985;21:995-1000
33. Keppel G. Design and Analysis: A Researcher's Handbook. Englewood Cliffs, NJ: Prentice Hall Inc; 1973
34. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. In: Kazdin AE, ed. Methodological Issues and Strategies in Clinical Research. Washington, DC: American Psychiatric Association; 1993
35. Barkley RA. Child behavior rating scales and checklists. In: Rutter M, Tuma H, Lann I, eds. Assessment and Diagnosis in Child Psychopathology. New York: Guilford Press; 1988
36. Swanson JM, Kinsbourne M, Roberts W, Zucker K. Time response analysis of the effects of stimulant medication in the learning ability of children referred for hyperactivity. Pediatrics. 1978;61:21-29
37. Werry JS, Sprague RL. Methylphenidate in children: effects of dosage. Aust N Z J Psychiatry. 1974;8:9-19
38. Conners CK, Barkley R. Rating scales and checklists for child psychopharmacology. Psychopharmacol Bull. 1985;21:816-832
39. Klein RG, Landa B, Mattes JA, Klein DF. Methylphenidate and growth in hyperactive children. A controlled withdrawal study. Arch Gen Psychiatry. 1988;45:1127-1130
40. Greenhill L, Puig-Antich J, Goetz R, Hanlon C, Davies M. Sleep architecture and REM sleep measures in prepubertal children with attention deficit disorder with hyperactivity. Sleep. 1983;6:91-101
41. Rechtshaffen A, Maron L. The effects of amphetamine on the sleep cycle. Electroencephalogr Clin Neurophysiol. 1964;16:438-445
42. Baekeland F. The effect of methylphenidate in the sleep cycle in man. Psychopharmacologia. 1966;10:179-183
43. Gadow KD, Nolan EE, Sverd J, Sprafkin J. School observations of ADHD children with tic disorder: effects of methylphenidate treatment. J Dev. Behav Pediatr. 1995;16:167-177
44. Fried JE. Use of Ritalin in the practice of pediatrics. In: Greenhill LL, Osman BB, eds. Ritalin: Theory and Patient Management. New York: Mary Ann Liebert Inc; 1991
45. DuPaul GJ, Barkley RA, McMurray MB. Response of children with ADHD to methylphenidate: interaction with internalizing symptoms. J Am Acad Child Adolesc Psychiatry. 1994;33:894-903
46. Pliszka SR. Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiatry. 1989;28:882-887
47. Tannock R, Ickowicz A, Schachar R. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiatry. 1995;34:886-896
48. Rapport MD, Denney C, DuPaul GJ, Gardner MJ. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry. 1994;33:882-893